Henoch-Schönlein purpura and drug and vaccine use in childhood: a case-control study

نویسندگان

  • Liviana Da Dalt
  • Claudia Zerbinati
  • Maria Stefania Strafella
  • Salvatore Renna
  • Laura Riceputi
  • Pasquale Di Pietro
  • Paola Barabino
  • Stefania Scanferla
  • Umberto Raucci
  • Nadia Mores
  • Adele Compagnone
  • Roberto Da Cas
  • Francesca Menniti-Ippolito
  • Francesca Menniti-Ippolito
  • Roberto Da Cas
  • Giuseppe Traversa
  • Carmela Santuccio
  • Patrizia Felicetti
  • Loriana Tartaglia
  • Francesco Trotta
  • Pasquale Di Pietro
  • Paola Barabino
  • Salvatore Renna
  • Laura Riceputi
  • Pier-Angelo Tovo
  • Clara Gabiano
  • Antonio Urbino
  • Luca Baroero
  • Daniele Le Serre
  • Silvia Virano
  • Liviana Da Dalt
  • Chiara Stefani
  • Claudia Zerbinati
  • Giorgio Perilongo
  • Marco Daverio
  • Michela Maretti
  • Beatrice Galeazzo
  • Giulia Rubin
  • Stefania Scanferla
  • Elena Chiappini
  • Sara Sollai
  • Maurizio De Martino
  • Sabrina Becciani
  • Martina Giacalone
  • Simona Montano
  • Giulia Remaschi
  • Alessia Stival
  • Piera Abate
  • Ilaria Leonardi
  • Nicola Pirozzi
  • Umberto Raucci
  • Antonino Reale
  • Rossella Rossi
  • Nadia Mores
  • Giulia Bersani
  • Adele Compagnone
  • Antonio Chiaretti
  • Riccardo Riccardi
  • Costantino Romagnoli
  • Vincenzo Tipo
  • Michele Dinardo
  • Fabiana Auricchio
  • Teodoro Polimeno
  • Maria Colomba Bonagura
  • Alessandra Maccariello
  • Fortunata Fucà
  • Eleonora Di Rosa
  • Domenica Altavilla
  • Anna Mecchio
  • Teresa Arrigo
چکیده

BACKGROUND Henoch-Schönlein purpura (HSP) is the most common vasculitis in childhood; nevertheless, its etiology and pathogenesis remain unknown despite the fact that a variety of factors, mainly infectious agents, drugs and vaccines have been suggested as triggers for the disease. The aim of this study was to estimate the association of HSP with drug and vaccine administration in a pediatric population. METHODS An active surveillance on drug and vaccine safety in children is ongoing in 11 clinical centers in Italy. All children hospitalized through the local Paediatric Emergency Department for selected acute clinical conditions of interest were enrolled in the study. Data on drug and vaccine use in children before the onset of symptoms leading to hospitalization were collected by parents interview. A case-control design was applied for risk estimates: exposure in children with HSP, included as cases, was compared with similar exposure in children with gastroduodenal lesions, enrolled as controls. HSP cases were validated according to EULAR/PRINTO/PRES criteria. Validation was conducted retrieving data from individual patient clinical record. RESULTS During the study period (November 1999-April 2013), 288 cases and 617 controls were included. No increased risk of HSP was estimated for any drug. Among vaccines, measles-mumps-rubella (MMR) vaccine showed an increased risk of HSP (OR 3.4; 95 % CI 1.2-10.0). CONCLUSIONS This study provides further evidence on the possible role of MMR vaccine in HSP occurrence.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

درمان کودک مبتلا به نفریت هنوخ شوئن لاینه‌ای با مایکوفنولیت مافتیل cellcept))

 Received: 18 Aug, 2008 Accepted: 14 Feb, 2009  Abstract  Renal involvement is one of the most serious sequela of Henoch-Schönlein purpura. The presence of proteinuria (nephritic range) and hematuria is also associated with progression to renal insufficiency. In fifty percent of patients who display a combination of nephritis-nephrotic symptoms, end-stage disease develops. Pharmacologic treatme...

متن کامل

Acute pancreatitis as a complication of anaphylactoid (Henoch-Schönlein) purpura.

A case of acute pancreatitis complicating anaphylactoid purpura (Henoch-Schönlein syndrome) is reported. In cases of this syndrome with abdominal pain, serum amylase levels should be estimated.

متن کامل

Partial response to anakinra in life-threatening Henoch-Schönlein purpura: case report

Henoch-Schönlein purpura is one of the most common forms of systemic vasculitis of childhood. We report the response to anakinra, the interleukin-1 receptor antagonist, in a 9 year old girl without prior medical problems who developed life-threatening Henoch-Schönlein vasculitis that produced renal failure, pulmonary hemorrhage and vasculitis of the brain. Her response supports the theory that ...

متن کامل

Henoch-Schönlein purpura in children.

Henoch-Schönlein purpura is the most common systemic vasculitis of childhood. In the majority of children, the outcome of Henoch-Schönlein purpura is excellent with spontaneous resolution of symptoms and signs. However, a small subset of patients will develop long-term sequelae in the form of chronic kidney disease. While the clinical presentation and diagnosis of Henoch-Schönlein purpura is st...

متن کامل

Vancomycin-induced Henoch-Schönlein purpura: a case report

INTRODUCTION Henoch-Schönlein purpura is a small-vessel systemic vasculitis. Although its exact pathophysiology remains unknown, Henoch-Schönlein purpura has been reported in association with various medical conditions including hypersensitivity. We report the case of a patient with vancomycin-induced Henoch-Schönlein purpura. CASE PRESENTATION A 42-year-old Caucasian man who had previously u...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 42  شماره 

صفحات  -

تاریخ انتشار 2016